Stock Taper 
BIB
$122.16
▲ UP 2.73% (3.25)
KEY STATISTICS
Market Cap$98.95 M
52w High$126.40
52w Low$54.56
Dividend Yield0.63%
FrequencyQuarterly
P/E34.60
Volume14.47K
Shares Out.810.03K
COMPANY
ABOUT
SECTOR
Financial Services
WENT PUBLIC
April 7, 2010
METHOD OF GOING PUBLIC
N/A
SPLIT RECORD
| DATE | TYPE | RATIO |
|---|---|---|
| 2015-05-20 | Forward | 2:1 |
| 2014-01-24 | Forward | 2:1 |
| 2012-10-05 | Forward | 2:1 |
PRICE
$122.16 ▲ UP 2.73% (+$3.25)About ProShares Ultra Nasdaq Biotechnology
https://www.proshares.com/our-etfs/leveraged-and-inverse/bib ↗ProShares Ultra Nasdaq Biotechnology is a U.S.-based ETF that uses derivatives to track twice the daily performance of the Nasdaq Biotechnology Index, investing in biotech, pharma, and healthcare stocks across market caps.
INDUSTRY
Asset Management
A SERVICE PROSHARES ULTRA NASDAQ BIOTECHNOLOGY IS KNOWN FOR
ProShares Ultra Nasdaq Biotechnology (BIB)
ProShares Ultra Nasdaq Biotechnology (BIB) is a leveraged ETF aiming to deliver twice the daily performance of the Nasdaq Biotechnology Index, targeting high-risk investors seeking amplified short-term biotech sector gains.